Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: CVRx Inc., 3 years.
CVRx Inc.
Director
SpyGlass Pharma Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
CVRx Inc. June 4, 202486.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | CVRx Inc. | Grant or award | +8,720 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +1,690,230 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +548,067 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +548,067 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +359,255 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Open-market purchase | +165,000 | $16.00 | $2,640,000 |
| May 15, 2025 | CVRx Inc. | Open-market purchase | +10,966 | $5.45 | $59,765 |
| May 14, 2025 | CVRx Inc. | Open-market purchase | +61,200 | $5.23 | $320,076 |
| May 13, 2025 | CVRx Inc. | Open-market purchase | +101,413 | $5.29 | $536,475 |
| May 12, 2025 | CVRx Inc. | Open-market purchase | +25,200 | $4.79 | $120,708 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.